Silva A, Mourao J, Vale N
Int J Mol Sci. 2025; 26(4).
PMID: 40003969
PMC: 11855824.
DOI: 10.3390/ijms26041506.
Work H, Kandel S, Lampe J
Drug Metab Dispos. 2024; 52(11):1224-1233.
PMID: 38702193
PMC: 11495666.
DOI: 10.1124/dmd.124.001598.
Qian L, Beers J, Jackson K, Zhou Z
Pharmaceutics. 2024; 16(4).
PMID: 38675145
PMC: 11054161.
DOI: 10.3390/pharmaceutics16040484.
Ringsten M, Kredo T, Ebrahim S, Hohlfeld A, Bruschettini M
Cochrane Database Syst Rev. 2023; 12:CD015087.
PMID: 38078559
PMC: 10712214.
DOI: 10.1002/14651858.CD015087.pub2.
Marques L, Vale N
Pharmaceutics. 2023; 15(6).
PMID: 37376035
PMC: 10301358.
DOI: 10.3390/pharmaceutics15061586.
Population pharmacokinetics of FCN-159, a MEK1/2 inhibitor, in adult patients with advanced melanoma and neurofibromatosis type 1 (NF1) and model informed dosing recommendations for NF1 pediatrics.
Tan Y, Cui A, Qian L, Li C, Wu Z, Yang Y
Front Pharmacol. 2023; 14:1101991.
PMID: 36755948
PMC: 9899833.
DOI: 10.3389/fphar.2023.1101991.
Characterization of fluorescent probe substrates to develop an efficient high-throughput assay for neonatal hepatic CYP3A7 inhibition screening.
Work H, Kandel S, Lampe J
Sci Rep. 2021; 11(1):19443.
PMID: 34593846
PMC: 8484451.
DOI: 10.1038/s41598-021-98219-x.
An Update on Pharmaceutical Strategies for Oral Delivery of Therapeutic Peptides and Proteins in Adults and Pediatrics.
Dan N, Samanta K, Almoazen H
Children (Basel). 2020; 7(12).
PMID: 33352795
PMC: 7766037.
DOI: 10.3390/children7120307.
Vancomycin pharmacokinetics in critically ill neonates receiving extracorporeal membrane oxygenation.
An S, Lee E, Kim J, Gwak H
Eur J Hosp Pharm. 2020; 27(e1):e25-e29.
PMID: 32296501
PMC: 7147555.
DOI: 10.1136/ejhpharm-2018-001720.
When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children.
Rodieux F, Vutskits L, Posfay-Barbe K, Habre W, Piguet V, Desmeules J
Front Pharmacol. 2018; 9:148.
PMID: 29556194
PMC: 5844975.
DOI: 10.3389/fphar.2018.00148.
Clinical Pharmacokinetics and Pharmacodynamics of Antihyperglycemic Medications in Children and Adolescents with Type 2 Diabetes Mellitus.
Akhlaghi F, Matson K, Mohammadpour A, Kelly M, Karimani A
Clin Pharmacokinet. 2016; 56(6):561-571.
PMID: 27832452
PMC: 5425330.
DOI: 10.1007/s40262-016-0472-6.
Clinical Pharmacokinetics of Penicillins, Cephalosporins and Aminoglycosides in the Neonate: A Review.
Pacifici G
Pharmaceuticals (Basel). 2016; 3(8):2568-2591.
PMID: 27713367
PMC: 4033939.
DOI: 10.3390/ph3082568.
Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndrome.
Elkomy M, Sultan P, Carvalho B, Peltz G, Wu M, Clavijo C
Clin Pharmacol Ther. 2015; 97(2):167-76.
PMID: 25670522
PMC: 4325425.
DOI: 10.1002/cpt.5.
Age-related changes in mRNA levels of hepatic transporters, cytochrome P450 and UDP-glucuronosyltransferase in female rats.
Kawase A, Ito A, Yamada A, Iwaki M
Eur J Drug Metab Pharmacokinet. 2014; 40(2):239-44.
PMID: 24899460
DOI: 10.1007/s13318-014-0208-7.
Pharmacokinetics of prophylactic cefazolin in parturients undergoing cesarean delivery.
Elkomy M, Sultan P, Drover D, Epshtein E, Galinkin J, Carvalho B
Antimicrob Agents Chemother. 2014; 58(6):3504-13.
PMID: 24733461
PMC: 4068446.
DOI: 10.1128/AAC.02613-13.
Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults.
Fernandez E, Perez R, Hernandez A, Tejada P, Arteta M, Ramos J
Pharmaceutics. 2013; 3(1):53-72.
PMID: 24310425
PMC: 3857037.
DOI: 10.3390/pharmaceutics3010053.
Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update.
Italiano D, Perucca E
Clin Pharmacokinet. 2013; 52(8):627-45.
PMID: 23640503
DOI: 10.1007/s40262-013-0067-4.
[Specific aspects of perioperative pain relief in children.].
Wangemann B
Schmerz. 1994; 8(2):82-94.
PMID: 18415441
DOI: 10.1007/BF02530413.
Tolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats.
Zissen M, Zhang G, McKelvy A, Propst J, Kendig J, Sweitzer S
Neuroscience. 2006; 144(1):247-62.
PMID: 17055659
PMC: 1858640.
DOI: 10.1016/j.neuroscience.2006.08.078.
Valproate as a mainstay of therapy for pediatric epilepsy.
Guerrini R
Paediatr Drugs. 2006; 8(2):113-29.
PMID: 16608372
DOI: 10.2165/00148581-200608020-00004.
